What he says about protein is wrong.
Single dose of donor stem cells raised walking endurance about 20% in frail older adults
Describes a trial of donor bone-marrow mesenchymal stem cells in 148 walking adults aged 70-85 with frailty (118 on varying doses, 30 on placebo). The cells lack immune-triggering surface proteins so no immunosuppressants were needed; at nine months the highest dose group walked about 60 m farther in a six-minute walk test than at baseline.

